Press release
March 23, 2021
Breakthrough Immunotherapy Earns First Regulatory Approval for Triple Negative Breast Cancer (TNBC)
ImmunopheresisTM therapy holds great promise for avoiding serious drawbacks of existing pharmaceuticals and improving patients’ quality of life
May 14, 2018